Advertisement

Topics

Companies Related to "Coronary venous angioplasty facilitate trans venous left ventricular" [Most Relevant Company Matches] [Advanced Search Results] RSS

17:46 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Coronary venous angioplasty facilitate trans venous left ventricular" found in our extensive corporate database of over 50,000 company records.

Showing "Coronary venous angioplasty facilitate trans venous left ventricular" Companies 1–25 of 613

Extremely Relevant

Venous Disease Coalition

The Venous Disease Coalition (VDC) is an alliance of more than 35 leading health professional societies and patient advocacy groups that have united around a common goal: To improve the survival rates and quality of life for individuals with, or at risk for, venous disease. The VDC plans to develop a national campaign to educate public and health care professionals in the U.S. about venous disease...


Vnus Medical Technologies

VNUS Medical Technologies, Inc. is dedicated to providing innovative products for treatment of venous disease. Our mission is to help patients look and feel better with safe, fast and more effective treatments for venous disease. VNUS Medical Technologies, founded in 1995, is a public company and world leader in the development and commercialization of products for minimally invasive treatment of...

InterVene Inc.

InterVene Inc. has developed the first non-implantable, catheter-based, vein valve creation therapy. The product is designed to treat chronic venous insufficiency (CVI) in the deep veins - a severely under-treated disease that causes painful venous stasis ulcers and other debilitating symptoms in millions of Americans annually. For more information, visit www....


NOVOSTE

Novoste Corporation, based in Atlanta, Georgia, develops advanced medical treatments for coronary and vascular diseases and is the worldwide leader in vascular brachytherapy - radiation therapy delivered inside a blood vessel to prevent its reclosure (restenosis) following balloon angioplasty and other catheter-based interventional procedures. The NovosteT Beta-CathT System is commercially availab...

EPIX Medical Incorporated

Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female sexual arousal dysfunction, atherosclerosis and myocardial perfusion. In addition to MS-325, EPIX's pipeline includes a new class of MR...

Stealth Therapeutics Inc.

Stealth Therapeutics was founded in 2006 for the purpose of designing and developing a portfolio of improved venous access devices. The technology is derived from the clinical practice of the company’s founder, Dr. Bradley Glenn. Dr. Glenn, a practicing interventional radiologist with strong interest and experience in venous access devices, guides Ste...

Thoratec

Thoratec Corporation is engaged in the research, development, manufacturing and marketing of medical devices for circulatory support, vascular graft, blood coagulation and skin incision applications. The Thoratec® Ventricular Assist Device (VAD) System approved for left, right, or total heart support and can be used as both a bridge-to-transplant and for recovery from open-heart surgery. More tha...

EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...

Sapheon Inc.

Sapheon is an early stage medical device company whose mission is to develop new approaches for the treatment of vascular disease. Our current focus is on developing technology to improve the treatment of venous reflux disease. Sapheon's newly developed vein closure technology responds to the inadequacies of existing venous reflux treatment options by usin...

Relevant

Venous Health Systems, Inc.

AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamics’ diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular...

NMT Medical

NMT Medical is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT is currently investigating the potential connection between a common heart defect that al...

NMT Medical, Inc.

NMT Medical is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT is currently investigating the potential connection between a common heart defect that al...

Enpath Medical

Enpath Medical is a leading supplier of venous vessel introducers, providing these products worldwide since 1985. Our broad range of introducer products includes slittable and peelable introducers, various locking mechanisms, a variety of materials - including FEP and PTFE - and other proprietary features that can be customized to fit the specific needs of individual customers. Enpath has als...

Tactile Medical

Tactile Medical headquartered in Minneapolis, MN is a leader in lymphedema and venous ulcer therapies, serving tens of thousands of patients throughout the U.S. The home therapy device company manufactures and provides products for patients with chronic edema, including the Flexitouch® System, an advanced pneumatic compression device and Entré System...

Ischemix

Ischemix is a privately-held drug discovery company with a portfolio of small molecule therapeutic compounds. The first of these compounds is targeted to reduce cell death and organ damage due to initial interruption and subsequent resumption of blood flow associated with cardiac surgeries and interventional procedures such as percutaneous coronary interve...

QTest Labs, Inc.

QTest Labs provides economical and rapid testing between drug discovery and preclinical trials . With a 2 week turn-around time and before conventional elaborate and expensive preclinical trials. QTest evaluates compounds for their effects on heart rate (RR interval), ventricular repolarization (QT and QTc), conductivity (P, PQ and QRS durations/intervals), inotropy (dP/dtmax), lusitropy (dP/dtmin...

B. Braun

Central venous catheters from B. Braun provide a simple, reliable and effective means of ensuring correct catheter placement without the use of x-ray monitoring. Our sales personnel would be pleased to provide you with further information and training materials

Argon Medical Devices, Inc.

Rex Medical, LP, based in Conshohocken, PA, is a privately held medical device company specializing in the development, manufacturing and marketing of minimally invasive medical devices targeted towards the cardiovascular, venous access, endosurgery and oncology markets.

EndoCross, Ltd.

Privately held EndoCross Ltd., headquartered in Yokneam Israel, and with operations in Amherst, New Hampshire (USA), has developed a proprietary system for the crossing of Chronic Total Occlusion (CTO). Through a combination of a unique balloon catheter design and the incorporation of a novel automated inflation system, the company’s ENABLER Catheter ...

BioVentrix

BioVentrix is a private corporation based in San Ramon, California. Its mission is to improve and expand on the surgical treatment of heart failure by left ventricular reconstruction, primarily through the development of less invasive catheter-based procedures. For more information, please visit www.bioventrix.com.

Trans-Hit Bio

Trans-Hit Bio is the worldwide biospecimen access CRO with a most extensive collection capability for biospecimens and clinical samples through an unrivalled worldwide partnered-network of state-of-the-art biorepositories. We facilitate direct interactions between Industry and Academic Biobanks allowing the scientific and medical expertise of academics to ...

Lantheus Medical Imaging, Inc. and NTP Radioisotopes

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in the field of diagnostic imaging provides a strong platform from which ...

PLC Systems

PLC is a global leader in the development of products for performing a revolutionary new surgical procedure known as transmyocardial revascularization (TMR). TMR offers a completely new medical treatment option for patients who suffer from severe coronary artery disease. Coronary artery disease is the leading cause of death in the United States. Working with leading researchers and premier heart...

Dallas Thrombosis Hemostasis & Difficult Hematology Clinical Center

Thrombosis is clearly the most common cause of death in the United States. About two million individuals in the U.S.A. die each year from an arterial or venous thrombosis or the consequences. By comparison, about 540,000 individuals in the USA die each year from cancer. About 80% to 90% of all causes of thrombosis can now be defined with respect to cause. Of these, up to 90% of all patients ha...


More From BioPortfolio on "Coronary venous angioplasty facilitate trans venous left ventricular"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks